Literature DB >> 24124270

The use of lung biopsy to determine early lung pathology and its association with health and production outcomes in feedlot steers.

Brandy A Burgess1, Steve H Hendrick, Colleen M Pollock, Sherry J Hannon, Sameeh M Abutarbush, Amanda Vogstad, G Kee Jim, Calvin W Booker.   

Abstract

The objectives of this study were to determine if percutaneous lung biopsy can be used to characterize early pathologic changes in bovine lung associated with bovine respiratory disease (BRD), to determine if specific infectious respiratory pathogens can be identified in association with these changes, and to determine whether pulmonary pathology at arrival and at the time of initial diagnosis are associated with health and production outcomes. One hundred auction-market derived crossbred steer calves from a commercial feedlot in southern Alberta were included in this study. A percutaneous lung biopsy technique was used to obtain lung samples from the right middle lung. Steers were sampled 295 times yielding 283 samples with 210 (74%) containing lung tissue. Overall, histopathological changes were observed in 20 (9.5%) of lung biopsy samples. There were too few samples with pathology to reveal an association between lung pathology and subsequent health events. In general, percutaneous lung biopsy can be done safely on feedlot steers in a commercial feedlot setting with few clinical side effects. This technique did not prove useful as a diagnostic tool or prognostic indicator for early BRD. However, it may be useful for the diagnosis of BRD in targeted populations of commercial feedlot steers.

Entities:  

Mesh:

Year:  2013        PMID: 24124270      PMCID: PMC3788659     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

1.  Prophylactic tilmicosin medication of feedlot calves at arrival.

Authors:  F J Schumann; E D Janzen; J J McKinnon
Journal:  Can Vet J       Date:  1990-04       Impact factor: 1.008

2.  Transbronchial lung biopsy: can specimen quality be predicted at the time of biopsy?

Authors:  F J Curley; J S Johal; M E Burke; A E Fraire
Journal:  Chest       Date:  1998-04       Impact factor: 9.410

3.  Relationships among treatment for respiratory tract disease, pulmonary lesions evident at slaughter, and rate of weight gain in feedlot cattle.

Authors:  T E Wittum; N E Woollen; L J Perino; E T Littledike
Journal:  J Am Vet Med Assoc       Date:  1996-08-15       Impact factor: 1.936

4.  The pattern of fatal fibrinous pneumonia (shipping fever) affecting calves in a large feedlot in Alberta (1985-1988).

Authors:  C S Ribble; A H Meek; G K Jim; P T Guichon
Journal:  Can Vet J       Date:  1995-12       Impact factor: 1.008

5.  Diseases and pathogens associated with mortality in Ontario beef feedlots.

Authors:  Mihai I Gagea; Kenneth G Bateman; Tony van Dreumel; Beverly J McEwen; Susy Carman; Marie Archambault; Rachel A Shanahan; Jeff L Caswell
Journal:  J Vet Diagn Invest       Date:  2006-01       Impact factor: 1.279

6.  A retrospective survey of diseases of feedlot cattle in Alberta.

Authors:  T L Church; O M Radostits
Journal:  Can Vet J       Date:  1981-02       Impact factor: 1.008

Review 7.  Respiratory diagnostic pathology.

Authors:  G A Andrews; G A Kennedy
Journal:  Vet Clin North Am Food Anim Pract       Date:  1997-11       Impact factor: 3.357

8.  The development of a novel percutaneous lung biopsy procedure for use on feedlot steers.

Authors:  Brandy A Burgess; Steve H Hendrick; Colleen M Pollock; Sameeh M Abutarbush; Amanda Vogstad; G Kee Jim; Calvin W Booker
Journal:  Can J Vet Res       Date:  2011-10       Impact factor: 1.310

9.  Percutaneous lung biopsy in cattle.

Authors:  U Braun; U Estermann; K Feige; T Sydler; A Pospischil
Journal:  J Am Vet Med Assoc       Date:  1999-09-01       Impact factor: 1.936

10.  Sequential lesions of experimental bovine pneumonic pasteurellosis.

Authors:  E M Allan; H A Gibbs; A Wiseman; I E Selman
Journal:  Vet Rec       Date:  1985-10-26       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.